Business Description
Ekso Bionics Holdings Inc
NAICS : 339112
SIC : 3841
ISIN : US2826442020
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.29 | |||||
Equity-to-Asset | 0.49 | |||||
Debt-to-Equity | 0.49 | |||||
Debt-to-EBITDA | -0.56 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -11.15 | |||||
Beneish M-Score | -2.73 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 2.1 | |||||
3-Year EBITDA Growth Rate | 23.2 | |||||
3-Year EPS without NRI Growth Rate | 12.6 | |||||
3-Year FCF Growth Rate | 10.3 | |||||
3-Year Book Growth Rate | 16.9 | |||||
Future 3-5Y Total Revenue Growth Rate | 24.85 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 65.07 | |||||
9-Day RSI | 57.18 | |||||
14-Day RSI | 52.45 | |||||
6-1 Month Momentum % | -4.78 | |||||
12-1 Month Momentum % | -17.25 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.81 | |||||
Quick Ratio | 2.11 | |||||
Cash Ratio | 1.2 | |||||
Days Inventory | 221.12 | |||||
Days Sales Outstanding | 110.72 | |||||
Days Payable | 102.08 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -21.2 | |||||
Shareholder Yield % | -24.22 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 50.41 | |||||
Operating Margin % | -77.71 | |||||
Net Margin % | -79.48 | |||||
FCF Margin % | -63.87 | |||||
ROE % | -87.88 | |||||
ROA % | -44.45 | |||||
ROIC % | -87.43 | |||||
ROC (Joel Greenblatt) % | -164.05 | |||||
ROCE % | -59.67 |
GF Value Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 1.13 | |||||
PB Ratio | 1.76 | |||||
Price-to-Tangible-Book | 2.88 | |||||
EV-to-EBIT | -1.72 | |||||
EV-to-EBITDA | -1.96 | |||||
EV-to-Revenue | 1.35 | |||||
EV-to-Forward-Revenue | 1.07 | |||||
EV-to-FCF | -2.02 | |||||
Price-to-Median-PS-Value | 0.26 | |||||
Price-to-Net-Current-Asset-Value | 4.52 | |||||
Earnings Yield (Greenblatt) % | -58.01 | |||||
FCF Yield % | -43.77 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Ekso Bionics Holdings Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 16.559 | ||
EPS (TTM) (€) | -0.897 | ||
Beta | 0.63 | ||
Volatility % | 98.56 | ||
14-Day RSI | 52.45 | ||
14-Day ATR (€) | 0.060913 | ||
20-Day SMA (€) | 1.19275 | ||
12-1 Month Momentum % | -17.25 | ||
52-Week Range (€) | 0.607 - 2.79 | ||
Shares Outstanding (Mil) | 18.17 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Ekso Bionics Holdings Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Ekso Bionics Holdings Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Ekso Bionics Holdings Inc Frequently Asked Questions
What is Ekso Bionics Holdings Inc(STU:23E2)'s stock price today?
When is next earnings date of Ekso Bionics Holdings Inc(STU:23E2)?
Does Ekso Bionics Holdings Inc(STU:23E2) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |